Nixon, Richard M.; Wonderling, David; Grieve, Richard D. - In: Health Economics 19 (2010) 3, pp. 316-333
Cost-effectiveness analyses (CEA) alongside randomised controlled trials commonly estimate incremental net benefits (INB), with 95% confidence intervals, and compute cost-effectiveness acceptability curves and confidence ellipses. Two alternative non-parametric methods for estimating INB are to...